NCT00002826 - Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 14, 1997

Primary Completion Date

November 30, 2003

Conditions

Breast Cancer

Interventions

DRUG

paclitaxel

DRUG

valspodar

Trial Locations (9)

Albert Einstein Comprehensive Cancer Center, The Bronx

Fox Chase Cancer Center, Philadelphia

Veterans Affairs Medical Center - Palo Alto, Palo Alto

Stanford University Medical Center, Stanford

Hunterdon Regional Cancer Program, Flemington

Kimball Medical Center, Lakewood

Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly

Cancer Institute of New Jersey, New Brunswick

St. Francis Medical Center, Trenton

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK